Science news

Home-based mobile guided cardiac rehabilitation is safe and effective in elderly patients with coronary heart disease or valvular interventions

High-intensity interval training is effective and safe in patients with heart failure with preserved ejection fraction

Time-Restricted Eating Shows No Weight Loss Benefit in RCT

Evinacumab Offers "Remarkable" Lipid Lowering in severe homozygous familial hypercholesterolemia

LoDoCo2: Added Steam for Colchicine as Secondary Prevention

EAST-AFNET 4: Early Rhythm Control in AF Gains New Life

EMPEROR-Reduced: Empagliflozin"s HFrEF Benefit Solidifies Class Effects

Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores

Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study

Cardiorespiratory Fitness May Alter AF Ablation Outcomes

Antihypertensive drugs linked to reduced risk of colorectal cancer

The relationship between smoking cessation and survival in young people with myocardial infarction in The Partners YOUNG-MI registry

Lipid-Lowering Bempedoic Acid Does Not Hasten or Worsen Diabetes

Correlation between statin use and overall and cardiovascular mortality in patients over 75 in the United States

Association of Positive Affect Instability With All-Cause Mortality in Older Adults in England

AAN Updates Advice on PFO Closure After Stroke

Late Dinner Affects Metabolism, May Lead to Weight Gain, Diabetes

VICTORIA: Vericiguat in the treatment of severe heart failure with a high risk of decompensation

A new class of lipid-lowering drugs for patients with a homozygous form of hypercholesterolemia

VOYAGER-PAD study: rivaroxaban is associated with a reducing incidence of major ischemic vascular events in patients with atherosclerotic peripheral artery disease